PhaseFolio
Atlas · Release History

Atlas Release History

Current release is 0.1.0. Each release below records what Atlas does, and the limits that apply to it, at the point it shipped.

What this history covers

Atlas is in beta. This history records product releases only. The methodology, API and dataset versions that appear in exports and citations are versioned separately and are not restated here. A release note describes what the product does; the source boundary shown in your account remains the authority for what you can include in a landscape.

0.1.0September 20, 2026Beta

First recorded Atlas beta release. Atlas builds a source-linked comparator landscape around a stated question, keeping each record traceable to the registry entry it came from.

  • Build a landscape from a comparison question, with the interpreted search scope shown and editable before any search runs.
  • Select which retrieved records belong in the comparison, and inspect any field down to its exact value, registry field path and capture metadata.
  • ClinicalTrials.gov is the activated source pack for comparator selection and evidence.
  • Where enabled for an account, the CTIS companion beta displays European Medicines Agency public-portal records for viewing only. This preview is separate from activated comparison sources and does not support selection, evidence packets or model analysis.
  • Fields a source does not report stay labelled as not reported, rather than blank or inferred.
  • Saved landscapes keep the question, search scope, selected records and evidence as they stood. Refreshing creates a new revision and leaves the earlier one intact.
Boundaries of this release
  • Atlas reports what sources say. It does not give treatment advice, benefit-risk conclusions, cross-study efficacy rankings, probability-of-success estimates or valuation verdicts.
  • A bounded result is not a complete universe. A source that was not searched is recorded as not searched, which is different from a source that returned nothing.
  • Source availability depends on your account and product lane. Creating an account does not by itself grant access to a source.